Pain sensitivity and muscle nerve signals in chronic knee pain and fibromyalgia
Studies nerve signals to muscles in adults with knee pain or fibromyalgia.
Key facts
- Who runs it
- University of Nottingham
- Where
- United Kingdom1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Investigating the Role of Central Pain Hypersensitivity in Skeletal Muscle Neural Drive
- Status
- Recruiting
- People taking part
- 135 people, planned
- Started
- 24 Nov 2025
- Planned end
- Sept 2026
- Type of study
- Observational, 3 groups
- Treatments tested
- Central Pain Hypersensitivity
- Record updated
- 15 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 40 years or over with long-lasting knee pain or fibromyalgia. It is also looking for healthy people without pain. It studies how pain relates to nerve signals sent to muscles.
- Age
- 40 years or over
- Sex
- All
- Disease stage
- Knee pain group: knee pain of 4 out of 10 or more on most days in the past 3 months. Fibromyalgia group: fibromyalgia diagnosed earlier by a clinician (self-reported), with pain of 4 out of 10 or more on most days in the past 3 months. Control group: pain-free people without known osteoarthritis.
Main reasons for not taking part
- BMI over 35 or body weight of 250kg (551 lb (250 kg)) or higher
- Pregnancy
- Not able to give consent or to complete the clinical tests
- Hard physical exercise in the 24 hours before testing
- Alcohol or caffeine on the day of testing
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Knee pain group
- History of knee pain with an intensity level of 4 out of 10 or greater (where 0 is no pain and 10 is the worst pain imaginable) for most days in the past 3 months; Fibromyalgia group
- Fibromyalgia diagnosis (participant self-reporting a previous diagnosis by a clinician)
- Pain with an intensity level of 4 out of 10 or greater (where 0 is no pain and 10 is the worst pain imaginable) for most days in the past 3 months; Control group
- Pain free individuals without known osteoarthritis
Who cannot take part
- Performed strenuous physical exercise in the past 24 hours prior to testing
- BMI>35
- Body weight of 250kg or higher
- Pregnancy (women)
- Inability to give consent
- Inability to meet the requirements of clinical assessment
- Consumed alcohol on day of testing
- Consumed caffeine on day of testing
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Background: pain lasting for 12 weeks or beyond, which is often referred to as chronic pain, is common for people living with musculoskeletal conditions (e.g. arthritis, low back pain and fibromyalgia). Pain is often not directly related to the degree of muscle or joint damage. Adaptations of the central nervous system (brain, spinal cord and nerves) often occur in chronic musculoskeletal conditions and can influence how we feel pain (central pain hypersensitivity). Pain can impact on muscle activity and movement. Muscle activity is also governed by nerve signals from the central nervous system (neural drive).
Read full original descriptionShow less
The goal of this cross-sectional observational study is to investigate whether chronic musculoskeletal pain is associated with altered nerve signalling (neural drive) to skeletal muscles in adults 40 years or over with chronic knee pain, fibromyalgia and healthy pain free volunteers.
The main questions it aims to answer are:-
* Is central pain hypersensitivity associated with altered nerve signalling to skeletal muscles in adults 40 years or over with chronic pain (knee pain and for fibromyalgia) as well as healthy volunteers? * Is altered nerve signalling to skeletal muscles associated with physical function and disability?
Participants will be asked to:-
* Have sensory testing to determine how they feel pain * Complete static leg and arm muscle contractions with electrodes on the skin to measure muscle electrical activity * Complete questionnaires * Perform a short set of mobility tasks including walking, rising from a chair and balancing.
The 3 groups in the trial
- Chronic Knee Pain
Adults with knee pain lasting over 3 months
Treatment: Central Pain Hypersensitivity
- Fibromyalgia
Adults with Fibromyalgia
Treatment: Central Pain Hypersensitivity
- Control Group
Adults without chronic pain conditions
Treatment: Central Pain Hypersensitivity
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Investigating the Role of Central Pain Hypersensitivity in Skeletal Muscle Neural Drive, in People With Knee Pain, and in People With Fibromyalgia Syndrome (Pain-Neural Drive)
- Plain-language title
- Pain sensitivity and muscle nerve signals in chronic knee pain and fibromyalgiaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 15 December 2025